Pic: Getty
Top 10 at 10: Which ASX stock is king of the pack today?
News
share
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.
It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has commenced trading.
WINNERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Code | Company | % | Volume | Price | Market Cap |
|---|---|---|---|---|---|
| RAP | Resapp Health Ltd | 55% | 5,776,643 | 0.096 | $53,270,218.77 |
| E33 | East 33 Limited. | 28% | 15,040 | 0.115 | $24,206,535.81 |
| MEB | Medibio Limited | 25% | 36,298 | 0.005 | $9,587,960.49 |
| CNJ | Conico Ltd | 17% | 8,147,773 | 0.014 | $12,002,578.49 |
| KNI | Kunikolimited | 16% | 486,218 | 1.61 | $57,646,168.96 |
| BUD | Buddy Tech | 14% | 61,800 | 0.008 | $24,587,674.62 |
| ICG | Inca Minerals Ltd | 14% | 967,048 | 0.12 | $50,527,223.04 |
| NOX | Noxopharm Limited | 14% | 249,862 | 0.365 | $93,516,144.00 |
| RGL | Riversgold | 14% | 6,750,486 | 0.041 | $16,727,274.90 |
| BSA | BSA Limited | 14% | 242,052 | 0.125 | $47,985,901.92 |
| AGH | Althea Group | 14% | 205,032 | 0.21 | $58,372,660.58 |
Health stock ResApp (ASX:RAP) has announced positive result for its new smartphone based COVID-19 screening test.
In a pilot clinical trial of 741 patients (446 COVID-19 positive) recruited in the United States and India, ResApp’s screening test, which uses machine learning to analyse the sound of a patient’s cough, was found to correctly detect COVID-19 in 92% of people with the infection.
Conico’s (ASX:CNJ) 50% owned ‘Mt Thirsty’ nickel-cobalt project in WA is far more attractive at current prices, JV partner Greenstone Resources (ASX:GSR) said today.
A drilling program at Inca Minerals’ (ASX:ICG) ‘Frewena’ IOCG-SEDEX project in the NT is due to start “imminently”.
Biotech Noxopharm (ASX:NOX) says its lead oncology drug candidate Veyonda has been granted Orphan Drug Designation (ODD) by the United States Food and Drug Administration (FDA) for its use in the treatment of soft tissue sarcoma.
And Riversgold (ASX:RGL) has picked up rock chips grading up to 2% lithium at its ‘Tambourah’ project in the Pilbara region of WA.
LOSERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Code | Company | % | Volume | Price | Market Cap |
|---|---|---|---|---|---|
| ANL | Amani Gold Ltd | -25% | 1,192,987 | 0.0015 | $45,866,882.25 |
| BAS | Bass Oil Ltd | -20% | 249,000 | 0.002 | $11,531,703.65 |
| SMX | Security Matters | -17% | 3,101 | 0.2 | $39,727,742.64 |
| GBR | Greatbould Resources | -12% | 1,920,297 | 0.145 | $58,943,908.49 |
| RNX | Renegade Exploration | -11% | 100,000 | 0.008 | $7,916,639.74 |
| AHI | Adv Human Imag Ltd | -11% | 619,789 | 0.335 | $62,531,018.25 |
| NCR | Nucoal Resources Ltd | -10% | 15,000 | 0.009 | $7,686,123.54 |
| PHO | Phosco Ltd | -10% | 39,907 | 0.14 | $37,408,699.29 |
| ARO | Astro Resources NL | -9% | 600,000 | 0.005 | $25,878,826.96 |
| MCM | Mc Mining Ltd | -9% | 13,878 | 0.1 | $16,986,151.05 |
